The burden of fungal disease in Denmark
- PMID: 26449502
- DOI: 10.1111/myc.12383
The burden of fungal disease in Denmark
Abstract
The aim of this study is to calculate the burden of fungal disease in Denmark. We identified all published epidemiology papers reporting fungal infection rates in Denmark. Where no data existed, we used numbers of specific populations at risk and fungal infection frequencies in those populations to estimate national incidence or prevalence. Approximately, one in six Danes will suffer from a fungal infection each year, most of which are skin or mucosal diseases causing disability but no deaths. Good data exist on candidaemia where a national voluntary reporting system is in place and have shown a high rate (9.6 per 100,000 inhabitants) compared other European countries. We present estimates of invasive aspergillosis and chronic pulmonary aspergillosis with rates of 4.4 per 100,000 and 3.1 per 100,000 inhabitants, respectively. Further studies are needed in order to better ascertain high-burden fungal infections such as recurrent vulvovaginal candidiasis (~1350 cases in 100,000 women) as well as allergic bronchopulmonary aspergillosis (~131 cases in 100,000 inhabitants) and severe asthma with fungal sensitisation (cases in 100,000 inhabitants). In conclusion, more than 93,000 Danes or about 2% of Denmark's population will have a non-trivial fungal infection during 1 year, which underscores the magnitude of the fungal burden.
Keywords: Aspergillosis; Denmark; HIV; candidiasis; fungal; global.
© 2015 Blackwell Verlag GmbH.
Similar articles
-
Burden of serious fungal infections in the Czech Republic.Mycoses. 2015 Oct;58 Suppl 5:6-14. doi: 10.1111/myc.12384. Mycoses. 2015. PMID: 26449501 Review.
-
Burden of fungal infections in Qatar.Mycoses. 2015 Oct;58 Suppl 5:51-7. doi: 10.1111/myc.12386. Mycoses. 2015. PMID: 26449507
-
Burden of serious fungal infections in Nepal.Mycoses. 2015 Oct;58 Suppl 5:45-50. doi: 10.1111/myc.12393. Mycoses. 2015. PMID: 26449506
-
Burden of serious fungal infections in Belgium.Mycoses. 2015 Oct;58 Suppl 5:1-5. doi: 10.1111/myc.12389. Mycoses. 2015. PMID: 26449500
-
The incidence and prevalence of serious fungal diseases in Tunisia.J Mycol Med. 2024 Jun;34(2):101479. doi: 10.1016/j.mycmed.2024.101479. Epub 2024 Apr 5. J Mycol Med. 2024. PMID: 38604083 Review.
Cited by
-
Strengthening the One Health Agenda: The Role of Molecular Epidemiology in Aspergillus Threat Management.Genes (Basel). 2018 Jul 19;9(7):359. doi: 10.3390/genes9070359. Genes (Basel). 2018. PMID: 30029491 Free PMC article.
-
Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces.Ther Adv Infect Dis. 2023 Dec 18;10:20499361231219315. doi: 10.1177/20499361231219315. eCollection 2023 Jan-Dec. Ther Adv Infect Dis. 2023. PMID: 38116297 Free PMC article.
-
Global Epidemiology of Mucormycosis.J Fungi (Basel). 2019 Mar 21;5(1):26. doi: 10.3390/jof5010026. J Fungi (Basel). 2019. PMID: 30901907 Free PMC article. Review.
-
An Estimate of the Burden of Fungal Disease in Norway.J Fungi (Basel). 2018 Feb 21;4(1):29. doi: 10.3390/jof4010029. J Fungi (Basel). 2018. PMID: 29466284 Free PMC article.
-
Determining the burden of fungal infections in Zimbabwe.Sci Rep. 2021 Jun 24;11(1):13240. doi: 10.1038/s41598-021-92605-1. Sci Rep. 2021. PMID: 34168204 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical